24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The study investigated the 24-hour efficacy and ocular surface health with preservative-free
tafluprost and a combined preservative-free regimen (tafluprost and dorzolamide/timolol fixed
combination) in open-angle glaucoma patients insufficiently controlled on latanoprost
monotherapy and showing signs, or symptoms of ocular surface disease with
preservative-containing latanoprost monotherapy. This trial randomized open-angle glaucoma
patients insufficiently controlled (IOP > 20 mm Hg) on branded, or generic latanoprost
monotherapy who required further IOP reduction and who demonstrated clinical signs, or
symptoms of ocular surface disease.